Jessup A - Search Results

1

Assessing the state of antibacterial drug discovery through patent analysis.

Sertkaya A, McGeeney JD, Sullivan C, Kolbe A, Beleche T, Murphy S, Berlind A, Jessup A. Sertkaya A, et al. Among authors: jessup a. Int J Antimicrob Agents. 2024 Feb;63(2):107051. doi: 10.1016/j.ijantimicag.2023.107051. Epub 2023 Dec 8. Int J Antimicrob Agents. 2024. PMID: 38072169

2

Key cost drivers of pharmaceutical clinical trials in the United States.

Sertkaya A, Wong HH, Jessup A, Beleche T. Sertkaya A, et al. Among authors: jessup a. Clin Trials. 2016 Apr;13(2):117-26. doi: 10.1177/1740774515625964. Epub 2016 Feb 8. Clin Trials. 2016. PMID: 26908540

3

Promoting Antibacterial Drug Development: Select Policies and Challenges.

Sertkaya A, Jessup A, Wong HH. Sertkaya A, et al. Among authors: jessup a. Appl Health Econ Health Policy. 2017 Feb;15(1):113-118. doi: 10.1007/s40258-016-0279-5. Appl Health Econ Health Policy. 2017. PMID: 27601239

4

Societal willingness to pay to avoid mortality and morbidity from Clostridioides difficile and carbapenem-resistant Enterobacteriaceae infections in the United States.

Sertkaya A, Wong HH, Ertis DH, Jessup A. Sertkaya A, et al. Among authors: jessup a. Am J Infect Control. 2019 May;47(5):521-526. doi: 10.1016/j.ajic.2018.11.008. Epub 2018 Dec 20. Am J Infect Control. 2019. PMID: 30579590

5

Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey.

Kolbe AR, Kearsley A, Merchant L, Temkin E, Patel A, Xu J, Jessup A. Kolbe AR, et al. Among authors: jessup a. BioDrugs. 2021 May;35(3):363-372. doi: 10.1007/s40259-021-00479-6. Epub 2021 Apr 7. BioDrugs. 2021. PMID: 33826078

6

Estimated Cost of Developing a Therapeutic Complex Medical Device in the US.

Sertkaya A, DeVries R, Jessup A, Beleche T. Sertkaya A, et al. Among authors: jessup a. JAMA Netw Open. 2022 Sep 1;5(9):e2231609. doi: 10.1001/jamanetworkopen.2022.31609. JAMA Netw Open. 2022. PMID: 36103178 Free PMC article.

7

Costs of Drug Development and Research and Development Intensity in the US, 2000-2018.

Sertkaya A, Beleche T, Jessup A, Sommers BD. Sertkaya A, et al. Among authors: jessup a. JAMA Netw Open. 2024 Jun 3;7(6):e2415445. doi: 10.1001/jamanetworkopen.2024.15445. JAMA Netw Open. 2024. PMID: 38941099 Free PMC article.

8

Projected US savings from biosimilars, 2021-2025.

Mulcahy A, Buttorff C, Finegold K, El-Kilani Z, Oliver JF, Murphy S, Jessup A. Mulcahy A, et al. Among authors: jessup a. Am J Manag Care. 2022 Jul;28(7):329-335. doi: 10.37765/ajmc.2022.88809. Am J Manag Care. 2022. PMID: 35852882 Free article.

9

Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users.

Stern AD, Chen JL, Ouellet M, Trusheim MR, El-Kilani Z, Jessup A, Berndt ER. Stern AD, et al. Among authors: jessup a. Health Aff (Millwood). 2021 Jun;40(6):989-999. doi: 10.1377/hlthaff.2020.02239. Health Aff (Millwood). 2021. PMID: 34097520

10

Economic Approaches to Estimating Benefits of Regulations Affecting Addictive Goods.

Cutler DM, Jessup AI, Kenkel DS, Starr MA. Cutler DM, et al. Among authors: jessup ai. Am J Prev Med. 2016 May;50(5 Suppl 1):S20-S26. doi: 10.1016/j.amepre.2015.12.002. Am J Prev Med. 2016. PMID: 27102854 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters